TMEM278
gene geneOn this page
Summary
TMEM278 (transmembrane protein 278, HGNC:37099) is a protein-coding gene on chromosome 1p36.33, encoding Transmembrane protein 278 (A6NKF7).
Predicted to be involved in negative regulation of canonical Wnt signaling pathway. Predicted to be located in membrane. Predicted to be active in plasma membrane.
Source: NCBI Gene 643965 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 33 total — 1 likely-pathogenic
- MANE Select transcript:
NM_001146685
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37099 |
| Approved symbol | TMEM278 |
| Name | transmembrane protein 278 |
| Location | 1p36.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000205116 |
| Ensembl biotype | protein_coding |
| Entrez | 643965 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000378821
RefSeq mRNA: 1 — MANE Select: NM_001146685
NM_001146685
CCDS: CCDS57964
Canonical transcript exons
ENST00000378821 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001478869 | 1425871 | 1426385 |
| ENSE00001751391 | 1427554 | 1430255 |
Expression profiles
Bgee: expression breadth broad, 98 present calls, max score 95.51.
FANTOM5 (CAGE): breadth broad, TPM avg 3.8898 / max 342.1792, expressed in 245 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 101 | 2.0699 | 182 |
| 104 | 1.3554 | 177 |
| 103 | 0.2148 | 87 |
| 105 | 0.1033 | 62 |
| 100 | 0.0705 | 40 |
| 102 | 0.0463 | 31 |
| 106 | 0.0294 | 9 |
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 95.51 | gold quality |
| substantia nigra | UBERON:0002038 | 90.19 | gold quality |
| primary visual cortex | UBERON:0002436 | 89.70 | gold quality |
| Ammon’s horn | UBERON:0001954 | 88.79 | gold quality |
| putamen | UBERON:0001874 | 87.26 | gold quality |
| temporal lobe | UBERON:0001871 | 85.10 | gold quality |
| amygdala | UBERON:0001876 | 84.94 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 83.45 | gold quality |
| caudate nucleus | UBERON:0001873 | 81.73 | gold quality |
| hypothalamus | UBERON:0001898 | 80.74 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 80.52 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 78.60 | gold quality |
| nucleus accumbens | UBERON:0001882 | 77.70 | gold quality |
| sural nerve | UBERON:0015488 | 73.84 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 72.87 | gold quality |
| right frontal lobe | UBERON:0002810 | 72.09 | gold quality |
| cerebral cortex | UBERON:0000956 | 69.41 | gold quality |
| brain | UBERON:0000955 | 69.31 | gold quality |
| tibial nerve | UBERON:0001323 | 62.84 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 61.85 | gold quality |
| cerebellum | UBERON:0002037 | 61.52 | gold quality |
| cerebellar cortex | UBERON:0002129 | 61.20 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 60.82 | gold quality |
| right uterine tube | UBERON:0001302 | 60.77 | gold quality |
| corpus callosum | UBERON:0002336 | 58.09 | gold quality |
| right testis | UBERON:0004534 | 56.37 | gold quality |
| left uterine tube | UBERON:0001303 | 55.67 | gold quality |
| frontal cortex | UBERON:0001870 | 55.37 | gold quality |
| left testis | UBERON:0004533 | 54.42 | gold quality |
| testis | UBERON:0000473 | 52.97 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.16 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tmem88b | ENSMUSG00000073680 |
| rattus_norvegicus | Tmem88b | ENSRNOG00000036869 |
Protein
Protein identifiers
Transmembrane protein 278 — A6NKF7 (reviewed: A6NKF7)
Alternative names: Transmembrane protein 88B
All UniProt accessions (1): A6NKF7
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the TMEM88 family.
RefSeq proteins (1): NP_001140157* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR033355 | TMEM88 | Family |
UniProt features (6 total): transmembrane region 2, region of interest 2, chain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NKF7-F1 | 66.88 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 18 (showing top):
GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY, GOBP_CANONICAL_WNT_SIGNALING_PATHWAY, GOBP_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY, LEIN_OLIGODENDROCYTE_MARKERS, chr1p36, GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN, GOBP_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY, GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP, GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP, GOBP_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY, WP_1P36_COPY_NUMBER_VARIATION_SYNDROME, GOBP_WNT_SIGNALING_PATHWAY, GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP, GOBP_NEGATIVE_REGULATION_OF_CELL_COMMUNICATION, GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN
GO Biological Process (1): negative regulation of canonical Wnt signaling pathway (GO:0090090)
GO Molecular Function (0):
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| negative regulation of Wnt signaling pathway | 1 |
| canonical Wnt signaling pathway | 1 |
| regulation of canonical Wnt signaling pathway | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
574 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM278 | TMEM179 | Q6ZVK1 | 476 |
| TMEM278 | DZANK1 | Q9NVP4 | 471 |
| TMEM278 | TMEM145 | Q8NBT3 | 469 |
| TMEM278 | ENTREP2 | O60320 | 452 |
| TMEM278 | SH2D7 | A6NKC9 | 447 |
| TMEM278 | FAM171B | Q6P995 | 445 |
| TMEM278 | FAM81A | Q8TBF8 | 439 |
| TMEM278 | RGSL1 | A5PLK6 | 429 |
| TMEM278 | TMEM91 | Q6ZNR0 | 422 |
| TMEM278 | TMPRSS5 | Q9H3S3 | 420 |
| TMEM278 | PXDC1 | Q5TGL8 | 415 |
| TMEM278 | AMER3 | Q8N944 | 406 |
| TMEM278 | RNF113B | Q8IZP6 | 400 |
| TMEM278 | RNF151 | Q2KHN1 | 400 |
| TMEM278 | SCCPDH | Q8NBX0 | 396 |
IntAct
0 interactions, top by confidence:
BioGRID (1): TMEM88B (Negative Genetic)
ESM2 similar proteins: A0A0U1RQ45, A0A0U1RQS6, A0A2R8YCJ5, A2A699, A2AEV7, A6NGB7, A6NJG2, A6NKF7, A6NKL6, A6NL88, A8MVW0, A9JSM3, B2RU40, B8ZZ34, C9JH25, D4A9R4, J3QNX5, P0CG09, P98077, Q0VD38, Q14761, Q17QH7, Q29RK8, Q2KJ18, Q2M3V2, Q3SX20, Q5BJT1, Q5HZJ5, Q5RKR3, Q5T442, Q64697, Q69YZ2, Q6PB97, Q6PCT2, Q6UXK2, Q6ZMQ8, Q6ZVH7, Q6ZW31, Q80XF7, Q8BLS7
Diamond homologs: A5D7M7, A6NKF7, Q0VD38, Q3TYP4, Q6PEY1, Q9D0N8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
33 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 29 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2685277 | GRCh37/hg19 1p36.33-36.32(chr1:1182855-2431925)x1 | Likely pathogenic |
SpliceAI
92 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:1426384:GG:G | donor_gain | 1.0000 |
| 1:1426385:GG:G | donor_gain | 1.0000 |
| 1:1426382:GAGG:G | donor_gain | 0.9900 |
| 1:1426384:GGGTG:G | donor_loss | 0.9900 |
| 1:1426385:GGTGA:G | donor_loss | 0.9900 |
| 1:1426386:G:A | donor_loss | 0.9900 |
| 1:1426386:G:GG | donor_gain | 0.9900 |
| 1:1426387:T:A | donor_loss | 0.9900 |
| 1:1426383:AGG:A | donor_gain | 0.9700 |
| 1:1426384:GGG:G | donor_gain | 0.9700 |
| 1:1426388:GA:G | donor_loss | 0.9500 |
| 1:1426381:CGAGG:C | donor_gain | 0.8700 |
| 1:1426382:GAGGG:G | donor_gain | 0.8700 |
| 1:1427642:C:A | acceptor_gain | 0.8400 |
| 1:1426386:G:T | donor_gain | 0.8300 |
| 1:1427639:T:A | acceptor_gain | 0.8100 |
| 1:1427550:CCAGG:C | acceptor_loss | 0.7200 |
| 1:1427551:CAGGT:C | acceptor_loss | 0.7200 |
| 1:1427552:A:C | acceptor_loss | 0.7200 |
| 1:1427544:C:A | acceptor_loss | 0.6300 |
| 1:1427636:C:CA | acceptor_gain | 0.6000 |
| 1:1427651:T:A | acceptor_gain | 0.6000 |
| 1:1427645:C:A | acceptor_gain | 0.5900 |
| 1:1427552:A:AG | acceptor_gain | 0.5700 |
| 1:1427553:G:GG | acceptor_gain | 0.5700 |
| 1:1427530:ACT:A | acceptor_loss | 0.5600 |
| 1:1427534:A:C | acceptor_loss | 0.5400 |
| 1:1426385:G:T | donor_gain | 0.5300 |
| 1:1426389:A:AC | donor_loss | 0.5300 |
| 1:1427051:GCCC:G | donor_gain | 0.5300 |
AlphaMissense
985 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:1427627:G:A | G111E | 0.972 |
| 1:1426366:G:A | G80E | 0.964 |
| 1:1426369:T:C | F81S | 0.952 |
| 1:1427626:G:A | G111R | 0.949 |
| 1:1427626:G:C | G111R | 0.949 |
| 1:1427618:T:A | I108N | 0.947 |
| 1:1426368:T:C | F81L | 0.946 |
| 1:1426370:C:A | F81L | 0.946 |
| 1:1426370:C:G | F81L | 0.946 |
| 1:1426342:C:A | P72H | 0.943 |
| 1:1426365:G:A | G80R | 0.943 |
| 1:1426365:G:C | G80R | 0.943 |
| 1:1426342:C:G | P72R | 0.940 |
| 1:1426379:C:A | H84Q | 0.934 |
| 1:1426379:C:G | H84Q | 0.934 |
| 1:1426375:G:A | C83Y | 0.932 |
| 1:1426374:T:A | C83S | 0.924 |
| 1:1426375:G:C | C83S | 0.924 |
| 1:1427642:C:G | P116R | 0.917 |
| 1:1426377:C:G | H84D | 0.913 |
| 1:1426369:T:G | F81C | 0.909 |
| 1:1426374:T:C | C83R | 0.904 |
| 1:1426357:T:A | V77D | 0.903 |
| 1:1426323:T:C | F66L | 0.901 |
| 1:1426325:C:A | F66L | 0.901 |
| 1:1426325:C:G | F66L | 0.901 |
| 1:1427626:G:T | G111W | 0.891 |
| 1:1426348:C:A | A74D | 0.884 |
| 1:1427615:T:A | L107H | 0.882 |
| 1:1427660:C:A | A122D | 0.882 |
dbSNP variants (sampled 300 via entrez): RS1000373339 (1:1430748 T>C), RS1000708901 (1:1429700 G>A,C), RS1001513434 (1:1429888 G>A), RS1001542388 (1:1425391 G>A), RS1001850397 (1:1428810 C>T), RS1002273370 (1:1425655 G>A), RS1002382248 (1:1428660 C>T), RS1002606914 (1:1424945 C>G,T), RS1002709347 (1:1427674 G>A,C,T), RS1002721519 (1:1424770 C>T), RS1002783147 (1:1429150 C>A), RS1002860608 (1:1430550 C>T), RS1003316209 (1:1428950 A>C,G), RS1003525090 (1:1427830 G>A,C), RS1004749891 (1:1427686 C>A,G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| beta-lapachone | decreases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | decreases reaction, increases expression | 1 |
| Vehicle Emissions | decreases reaction, increases expression | 1 |
| Gold Compounds | increases expression | 1 |
| Particulate Matter | increases expression, decreases reaction | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.